| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC | EVP and Chief Medical Officer | Common Stock | 130,264 | $4,204,935 | $32.28 | 10 Feb 2022 | Direct |
| Channel Therapeutics Corp | Director | Restricted Stock Units | 28,012 | $112,615 | $0.9700 | 02 Jul 2025 | Direct |
| Chromocell Therapeutics Corp | Director | Common Stock | 91,565 | $86,501 | $0.9447 | 12 Sep 2024 | Jointly held with spouse |
| Channel Therapeutics Corp | Director | Stock Option | 58,230 | 02 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CHRO | Pelthos Therapeutics Inc. | 02 Jul 2025 | 2 | $0 | 4 | Director | 07 Jul 2025, 21:41 |
| CHRO | Chromocell Therapeutics Corp | 13 Nov 2024 | 1 | $0 | 4 | Director | 15 Nov 2024, 16:20 |
| CHRO | Chromocell Therapeutics Corp | 12 Sep 2024 | 1 | +$9,825 | 4 | Director | 16 Sep 2024, 16:56 |
| CHRO | Chromocell Therapeutics Corp | 14 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 20:02 |
| CHRO | Chromocell Therapeutics Corp | 15 Feb 2024 | 0 | $0 | 3 | Director | 15 Feb 2024, 20:14 |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | 10 Feb 2022 | 4 | -$111,069 | 4 | EVP and Chief Medical Officer | 14 Feb 2022, 17:49 |